AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06654206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Supervised strength exercise sessions: There will be two sessions per week, each lasting 50 minutes. Each session will consist of three distinct parts:~Warm-up: 10 minutes of global strength and aerobic exercises at 60% of estimated VO2max, focusing on the areas that will primarily be worked on during that session.~Strength training: 6 strength exercises targeting the major muscle groups, lasting 30 minutes. The initial load will be set between 40-70% of the estimated 1-RM (assessed in the first session and based on the individual patient). When the participant is able to complete 3 sets of 12 repetitions with the established weight in two consecutive sessions, the weight will be increased by 10%. The exercises will be performed in a circuit format with 30 seconds of rest between exercises and 90 seconds of rest between sets.~Cool-down/stretching: 10 minutes of a combination of breathing exercises and stretching for the major muscle groups.~Promotion of physical activity: Participants
Study NCT05488444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Navigator Phone Calls
Description: The patient navigator will call you every week as described above in Study Groups. These phone calls will continue until you begin receiving chemotherapy.
Study NCT05488444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exit Interview
Description: Participants will be asked to complete an exit interview either in person or by phone
Study NCT05788770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FEops HEARTGuide
Description: FEops HEARTGuide added to routine preoperative CT imaging. Results of the computer modelling will be discussed with TAVR implanting team prior to and during the procedure.
Study NCT06503614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab 1500mg IV
Study NCT06503614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monalizumab
Description: Monalizumab 1500mg IV
Study NCT06599281 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Physiotherapy
Description: The physical therapy program was applied for 3 months, 6 days a week, 2 sessions per day, and an average session duration of 45 minutes. Each neurodevelopmental exercise and proprioceptive exercise was applied for 10 minutes, and stretching exercises were applied for 45 seconds and 3 repetitions. The exercises included functional rotation, sitting with or without arm support, crawling, kneeling, half kneeling, standing up by holding on, and sequencing exercises. Stretching exercises were mostly positional stretches aimed at lateral flexion of the spine.
Study NCT06595134 — intervention group
Intervention type: OTHER
Intervention: Non Interventional
Description: Screening (Day -7 to Day -1) Visit 1 (Day 0) Visit 2 (Month 3 +/- 7 days) Visit 3 (Month 6 +/- 7 days) Visit 4 (Month 12 +/- 7 days) Visit 5 (Month 24 +/- 7 days) Visit 6 (Month 60 +/- 30 days; end of study)
Study NCT06248996 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherpy
Description: 83.0 Gy in 68 fractions, 1.22 Gy per fraction, two daily fractions, five days per week to the primary tumour volume (GTVT_83.0). To the primary tumour with an added margin (PTVT_74.8) and to neck node metastases (PTVN_74.8) the prescribed dose will be 74.8 Gy in 68 fractions, 1.10 Gy per fraction twice daily. To elective neck nodes (PTV 54.4) the prescribed dose will be 54.4 Gy in 68 fractions, 0.80 Gy per fraction twice daily.
Study NCT06248996 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: 68.0 Gy in 34 fractions, 2.00 Gy per fraction per day, five or six days per week to tumour volumes and 54.4 Gy in 34 fractions, 1.60 Gy per fraction to elective neck nodes.
Study NCT05106426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Caregivers- Healthy children
Description: The HC2 intervention is an obesity prevention program that provides nutrition and healthy activities programs administered weekly via Zoom or in-person.
Study NCT05106426 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Jump Start
Description: The Jump Start intervention is a behavioral health and safety program that provides behavior management and safety programs administered weekly via Zoom or in-person.
Study NCT06440434 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Time of night shift
Description: Early vs. late night split night shift
Study NCT06109636 — intervention group
Intervention type: OTHER
Intervention: Pentacam, Corvis ST and Casia2
Description: scleral and ciliary muscle thickness were obtained by Casia2, biomechanical parameters were obtained by Pentacam and Corvis ST
Study NCT04961151 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal therapeutic warming w/ esophageal d/c
Description: In order to evaluate the ability to reliably raise patient temperature to a target of 39.0°C, patients will be warmed with forced air warming, surface conductive warming, and esophageal core warming. After 4 hours at target temperature, esophageal warming will be discontinued.
Study NCT04961151 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal therapeutic warming w/ conductive d/c
Description: In order to evaluate the ability to reliably raise patient temperature to a target of 39.0°C, patients will be warmed with forced air warming, surface conductive warming, and esophageal core warming. After 4 hours at target temperature, conductive warming will be discontinued.
Study NCT05360173 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acupressure
Description: The researcher use thumb and put about 3 kilogram on four acupoints where locating on the patient's arm and leg.
Study NCT05360173 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: sham acupressure
Description: The researcher use thumb and put about 3 kilogram on four acupoints where locating at about 3 cm next to the acupoint on the patient's arm and leg.
Study NCT05604820 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercise
Description: Training on progressive muscle relaxation exercises will be given to the experimental group in the chemotherapy unit. Before going to sleep in the evening and during the day, they will be asked to do progressive muscle relaxation exercises in line with the instruction of the video. They will be asked to do the application every day for 8 weeks. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. Only routine care will be applied to the control group and no intervention will be made. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. After the evaluations, information about progressive muscle relaxation exercises will be given.
Study NCT04404998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower Energy Density
Description: Test meal with lower energy density
Study NCT04404998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Higher Energy Density
Description: Test meal with higher energy density
Study NCT04404998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower Satiation
Description: Information on lower satiation
Study NCT04404998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Higher Satiation
Description: Information on higher satiation
Study NCT05895682 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mobiCARE +Pulse (MP100W)
Description: Volunteers were monitored using end-tidal carbon dioxide partial pressure and fraction of inspired oxygen. Each volunteer was placed in a semi-Fowler's position and connected to a breathing circuit to administer the nitrogen-air-carbon dioxide mixtures. A nose clip was applied to prevent breathing of room air. For frequent blood sampling, an arterial cannula was placed in the radial artery of each volunteer. Pulse oximeter probes were simultaneously attached to each volunteer's fingers. Each volunteer was exposed to various levels of induced hypoxia from 70\~100% of SaO2. Each plateau of oxygen saturation was maintained for at least 30 s until stabilization, after which 1 ml of arterial blood was drawn into a heparinized syringe. The study period consisted of two rounds of hypoxia, and the volunteers were maintained on room air between each round. SaO2 measurements using a CO-oximeter were used as a reference for the SpO2 accuracy.
Study NCT05755295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: horse therapy
Description: equitherapy and hippotherapy once a week during 16 weeks
Study NCT05929898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
Description: fMRI neurofeedback training of sustained midbrain/VTA activation via motivational imagery.
Study NCT06226909 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: different types of ultrasound technique
Description: Shear-wave elastography-guided or B-mode ultrasound-guided
Study NCT06226909 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different types of ultrasound technique
Description: Shear-wave elastography-guided or B-mode ultrasound-guided
Study NCT04669340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-learning patient education
Description: The intervention implies patient education through an e-learning program. The program consists of three learning modules covering knowledge of rheumatoid arthritis, medication, examinations, complications and daily living with RA. Module 1 consists of 'need to know' information about disease management, symptoms and medication. Thus, it is mandatory and must be completed before entering module 2 and 3. In module 2 and 3, patients can move around on the basis of their individual needs.~The duration of the full program is approximately two hours, but may vary dependent on the individual user needs. The program may be used as much as needed throughout the study period.
Study NCT04669340 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard face-to-face patient education
Description: The intervention implies usual care, i.e. face-to-face patient education in a one-hour session with a nurse at the hospital. This form of patient education is based on the patients individual need for information and guidance in relation to rheumatoid arthritis and medication. Thus, aspects of daily life with the disease is discussed at the beginning and forms the conversation. However, as a standard, information of the disease, disease management, symptoms and medication must be discussed with the patient and relatives.
Study NCT05404399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Free From Pain Exercise Book
Description: Participants in Group 1 will be provided with the Free From Pain Exercise Book.
Study NCT05404399 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Participants in Group 2 would be referred to Physiotherapy (usual care)
Study NCT05788744 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ctDNA
Description: ctDNA guided surveillance
Study NCT06476210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDL regimen
Description: Drug:bedaquiline 100mg tablets~Other Names:~Bdq TMC-207 bedaquiline 400 mg once daily for 2 weeks then 200mg 3 times per week~Drug:delamanid 50mg tablets~Other Names:~Dlm OPC-67683 delamanid 100mg 2 times daily~Drug:linezolid Scored 600mg tablets~Other Names:~Lzd linezolid 600mg once daily
Study NCT05627375 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Full-dose anticoagulant therapy (AC)
Description: Anticoagulant (AC) therapy: at the investigator's discretion in accordance with international recommendations for the management of DVT/PE
Study NCT05627375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulant therapy (AC)
Description: Anticoagulant (AC) therapy: at the investigator's discretion in accordance with international recommendations for the management of DVT/PE
Study NCT05627375 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antiplatelet therapy (AP)
Description: Aspirin (at a daily dose ≤100 mg) or Clopidogrel (at a daily dose ≤75mg)
Study NCT06174623 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ModulHeart Support
Description: The ModulHeart device will be implanted in the descending abdominal aorta.
Study NCT06295939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: social support program
Description: Group 2, the experimental group, will receive routine nursing care from the assigned nurse and a social support program provided by the researcher, as follows:~Phase 1 (Before Pregnancy Termination)~Phase 2 (After Pregnancy Termination, Before Returning Home):
Study NCT06295939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine nursing care
Description: The sample group will receive routine nursing care from the assigned nurse.
Study NCT05872802 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric exercises and electrical stimulation
Description: Eccentric exercises and strengthening currents to improve ankle dorsiflexion in professional padel players.
Study NCT05872802 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: proprioceptive neuromuscular facilitation
Description: proprioceptive neuromuscular facilitation to improve ankle dorsiflexion in professional padel players.
Study NCT05449990 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participation in PFCC-IR
Description: Patient-and-family-centered-care interdisciplinary rounds (PFCC-IR) with the critical care team are standard practice in the ICU but it doesn't usually include family members. The intervention for this study is PFCC-IR that include one family member of the patient.
Study NCT06452966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional Chinese medicine
Description: patients in the group will receive one of or a combination of the following interventions:~Oral Chinese medicine decoction:~The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks.~Acupuncture or low level laser acupuncture treatment:~Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks.~the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs.~in addition, the patients will recive ICU care and medication based on patient's needs.
Study NCT06452966 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine ICU care
Description: Patients will receive ICU care
Study NCT06452966 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: historical Routine ICU care
Description: Patients had received ICU care
Study NCT00535314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 402 Dose1
Study NCT00535314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 402 Dose2
Study NCT02712151 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Abdominal Wall Block
Description: bilateral TAP and RS blocks.
Study NCT02712151 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical infiltration
Description: distributed between the 4 laparoscopic port sites.
Study NCT02712151 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sterile saline
Description: Placebo injection
Study NCT02712151 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.2%
Description: Ropivacaine 0.2% 1.0 ml/kg total in divided doses for bilateral TAP and RS blocks.
Study NCT02712151 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: For nerve localization
Study NCT02712151 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.5%
Description: Ropivacaine 0.5% 0.4 ml/kg total in divided doses distributed between the 4 laparoscopic port sites
Study NCT05273476 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: apically repositioned flap+ xenogeneic collagen matrix +free gingival graft
Description: Harvest a strip free gingival graft from the palate, then place it above apically repositioned flap and fix xenogeneic collagen matrix to the recipient bed
Study NCT05235945 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online exercise intervention
Description: Described in arm descriptions
Study NCT05472766 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Direct Acting Oral Anticoagulant starting at Day 30
Description: Dabigatran, Rivaroxaban, Apixaban or Edoxaban at standard dose as recommended by the MRP
Study NCT05472766 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Direct Acting Oral Anticoagulant starting at Day 90
Description: Dabigatran, Rivaroxaban, Apixaban or Edoxaban at standard dose as recommended by the MRP
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calaspargase Pegol
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase Pegol
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytarabine
Description: Given IT, IV or SC
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IT, IV or SC
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daunorubicin
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: Undergo echocardiography
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Puncture
Description: Undergo lumbar puncture
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Puncture
Description: Undergo lumbar puncture
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mercaptopurine
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mercaptopurine
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: Given IT
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Given IT
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA scan
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA scan
Study NCT06210750 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Navitoclax
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nelarabine
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nelarabine
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pegaspargase
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegaspargase
Description: Given IV